Esomeprazole
Generic Details
Generic Name
Esomeprazole
Other Names
- Nexium
Drug Class
- Proton pump inhibitor
Chemical Formula
C17H19N3O3S
Molecular Weight
345.42 g/mol
Mechanism of Action
- Inhibits the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a reduction in gastric acid secretion.
Indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcers
- Helicobacter pylori eradication therapy
- Zollinger-Ellison syndrome
Common Dosage Forms
- Capsules
- Tablets
- Powder for oral suspension
Typical Dosage
- 20-40 mg once daily for GERD
Pediatric Dosage
- Safety and efficacy not established in children under 1 year old
Geriatric Dosage
- No dosage adjustment necessary for elderly patients
Side Effects
- Headache
- Nausea
- Abdominal pain
- Diarrhea
- Vitamin B12 deficiency with long-term use
Contraindications
- Hypersensitivity to esomeprazole or substituted benzimidazoles
Pregnancy Category
- Category C - Risk cannot be ruled out
Lactation Safety
- Compatible with breastfeeding, minimal risk expected
Drug Interactions
- May interact with drugs that require gastric acid for absorption (e.g., ketoconazole, atazanavir)
Overdose Symptoms
- Confusion
- Drowsiness
- Blurred vision
- Dry mouth
Antidote for Overdose
- No specific antidote, treatment is supportive
Storage Conditions
- Store at room temperature (15-30°C)
- Protect from light and moisture
Pharmacokinetics
- Absorption: Rapidly absorbed from the gastrointestinal tract
- Distribution: Protein binding is approximately 97%
- Metabolism: Primarily hepatic via CYP2C19 and CYP3A4 enzymes
- Excretion: Mainly excreted in the urine
Precautions
- Monitor magnesium levels with long-term use
- Avoid abrupt discontinuation to prevent rebound acid hypersecretion
Warnings
- Increased risk of Clostridium difficile-associated diarrhea
- Possible increased risk of bone fractures with long-term therapy
Others
- May increase the risk of community-acquired pneumonia